Detecting PKC phosphorylation as part of the Wnt/calcium pathway in cutaneous melanoma

Methods in Molecular Biology

Volumn 468, Issue , 2008, Pages 157-172

  Dissanayake, Samudra K ^a   Weeraratna, Ashani T ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Melanoma; PKC; Protein kinase C; Wnt5A

Indexed keywords

CALCIUM; HYBRID PROTEIN; ISOENZYME; PROTEIN KINASE C; SMALL INTERFERING RNA; WNT PROTEIN;

ARTICLE; GENETICS; HUMAN; MELANOMA; METABOLISM; METHODOLOGY; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN TUMOR; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CALCIUM; CELL LINE, TUMOR; HUMANS; ISOENZYMES; MELANOMA; PHOSPHORYLATION; PROTEIN KINASE C; RECOMBINANT FUSION PROTEINS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; WNT PROTEINS;

EID: 58749110357     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-249-6_12     Document Type: Article

References (13)

1. Kuhl, M., Sheldahl, L. C., Park, M., Miller, J. R., and Moon, R. T. (2000) The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet 16, 279-283.
2. Bittner, M., Meltzer, P., Chen, Y., Jiang, Y., Seftor, E., Hendrix, M., et al. (2000) Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536-540.
3. Weeraratna, A. T., Jiang, Y., Hostetter, G., Rosenblatt, K., Duray, P., Bittner, M., et al. (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1, 279-288.
4. Dissanayake, S. K., Wade, M. S., Johnson, C. E., O'Connell, M. P., Leotlela, P. D., French A.D., et al. (2007) The Wnt5a/Pkc pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors, and initiation of an epithelial to mesenchymal transition. J Biol Chem 282, 17259-17271.
5. Parker, C., and Sherbet, G. V. (1992) Modulators of intracellular Ca2+ and the calmodulin inhibitor W-7 alter the expression of metastasis-associated genes MTS1 and NM23 in metastatic variants of the B16 murine melanoma. Melanoma Res 2, 337-343.
6. Li, S., Huang, S., and Peng, S. B. (2005) Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression. Int J Oncol 27, 1329-1339.
7. Fink-Puches, R., Helige, C., Kerl, H., Smolle, J., and Tritthart, H. A. (1993) Inhibition of melanoma cell directional migration in vitro via different cellular targets. Exp Dermatol 2, 17-24.
8. Oka, M. and Kikkawa, U. (2005) Protein kinase C. in melanoma. Cancer Metastasis Rev 24, 287-300.
9. Lahn, M. M. and Sundell, K. L. (2004) The role of protein kinase C-alpha (PKC-alpha) in melanoma. Melanoma Res 14, 85-89.
10. Maya, R. and Oren, M. (2000) Unmasking of phosphorylation-sensitive epitopes on p53 and Mdm2 by a simple Western-phosphatase procedure. Oncogene 19, 3213-3215.
11. Sheldahl, L. C., Park, M., Malbon, C. C., and Moon, R. T. (1999) Protein kinase C. is differentially stimulated by Wnt and Frizzled homologs in a G-protein-dependent manner. Curr Biol 9, 695-698.
12. Keranen, L. M., Dutil, E. M., and Newton, A. C (1995) Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Curr Biol 5, 1394-1403.
13. Leotlela, P. D., Wade, M. S., Duray, P. H., Rhode, M. J., Brown, H. F., Rosenthal, D. T., et al. (2007) Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene 26, 3846-3856.